Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Consumer Discretionary ETF Vanguard | VCR | Nov 22, 2024 | 368.50 | +1.60 |
Consumer Portfolio Services | CPSS | Nov 22, 2024 | 10.55 | -1.03 |
Consumer Staples Alphadex First Trust | FXG | Nov 22, 2024 | 68.91 | +0.70 |
Consumer Staples ETF Vanguard | VDC | Nov 22, 2024 | 220.23 | +1.08 |
Consumer Staples Select Sector SPDR | XLP | Nov 22, 2024 | 81.84 | +0.92 |
Consumers Energy Pref | CMS-B | Nov 22, 2024 | 80.84 | -0.15 |
Container Store | TCS | Nov 22, 2024 | 3.97 | +2.32 |
Contango ORE | CTGO | Nov 22, 2024 | 18.73 | -2.55 |
Context Therapeutics | CNTX | Nov 22, 2024 | 1.39 | -7.33 |
Contextlogic A | LOGC | Nov 22, 2024 | 7.10 | +2.01 |
Contineum Therapeutics | CTNM | Nov 22, 2024 | 14.09 | -1.74 |
Continuous Commodity Index | GCC | Nov 22, 2024 | 19.11 | +1.03 |
Controladora Vuela Compania de Aviacion ADR | VLRS | Nov 22, 2024 | 7.77 | -2.63 |
Cool Company | CLCO | Nov 22, 2024 | 8.81 | -4.45 |
Cooper-Standard | CPS | Nov 22, 2024 | 14.42 | +2.41 |
Copa | CPA | Nov 22, 2024 | 93.37 | +0.66 |
Copart | CPRT | Nov 22, 2024 | 62.70 | +10.19 |
Corbus Pharmaceuticals | CRBP | Nov 22, 2024 | 17.47 | +4.42 |
Corcept Therapeutics | CORT | Nov 22, 2024 | 57.54 | +2.90 |
Core & Main A | CNM | Nov 22, 2024 | 45.27 | +1.57 |
Core Laboratories | CLB | Nov 22, 2024 | 21.28 | +0.76 |
Core Molding Technologies | CMT | Nov 22, 2024 | 17.50 | +3.67 |
Core Scientific | CORZ | Nov 22, 2024 | 18.23 | +3.87 |
Corebridge Financial | CRBG | Nov 22, 2024 | 31.75 | +0.89 |
CoreCard | CCRD | Nov 22, 2024 | 19.71 | +5.68 |
CoreCivic | CXW | Nov 22, 2024 | 22.01 | +0.96 |
CorMedix | CRMD | Nov 22, 2024 | 9.96 | -3.58 |
Cornerstone Stategic | CLM | Nov 22, 2024 | 8.79 | +1.03 |
Cornerstone Total Return Fund | CRF | Nov 22, 2024 | 9.01 | +1.12 |
Corning | GLW | Nov 22, 2024 | 48.52 | +1.42 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.